glp-1 coverage insurance news today How to Afford GLP-1s in 2026: What to Know About and Alternative Options Some insurers are dropping GLP-1

LegitScripts findings show both a rapid rise in demand for Healthcare Certification by businesses offering compounded GLP-1 drugs, as well as a sharp increase in problematic GLP-1 products being peddled online that are violating laws across jurisdictions worldwide and potentially endangering unsuspecting consumers.

This guide explores the key differences, benefits, and considerations to help

Again, every person and situation is different

Learn what to expect from compounded GLP-1/GIP injections here.

A large retrospective cohort study of 111,646 overweight or obese women found that GLP-1 agonist exposure was associated with lower breast cancer incidence

The widespread patient demand for semaglutide (Ozempic ) has created unprecedented challenges for GPs